Trial intelligence / Profile preview

GMFFP From Young Healthy Donors to Ameliorate Frailty in Older Individuals

NCT03458429Phase 2Enrolling by invitation

Start
Feb 2018
Primary completion
Dec 2029
Modality
Tissue Cells
Countries
1
01

Overview

A Phase 2 trial of GMFFP in frailty syndrome. Started Feb 2018; status: enrolling by invitation.

02

Drugs

GMFFP
03

Conditions

frailty syndrome

Beyond the preview

Go deeper on NCT03458429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03458429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call